AAAAAA

   
Results: 1-7 |
Results: 7
MARKERS OF TUMOR ANGIOGENESIS AND PROTEOLYSIS INDEPENDENTLY DEFINE HIGH-RISK AND LOW-RISK SUBSETS OF NODE-NEGATIVE BREAST-CANCER PATIENTS
Authors: EPPENBERGER U KUENG W SCHLAEPPI JM ROESEL JL BENZ C MUELLER H MATTER A ZUBER M LUESCHER K LITSCHGI M SCHMITT M FOEKENS JA EPPENBERGERCASTORI S
Citation: U. Eppenberger et al., MARKERS OF TUMOR ANGIOGENESIS AND PROTEOLYSIS INDEPENDENTLY DEFINE HIGH-RISK AND LOW-RISK SUBSETS OF NODE-NEGATIVE BREAST-CANCER PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3129-3136
PH-SENSITIVE NANOPARTICLES - AN EFFECTIVE MEANS TO IMPROVE THE ORAL DELIVERY OF HIV-1 PROTEASE INHIBITORS IN DOGS
Authors: LEROUX JC COZENS RM ROESEL JL GALLI B DOELKER E GURNY R
Citation: Jc. Leroux et al., PH-SENSITIVE NANOPARTICLES - AN EFFECTIVE MEANS TO IMPROVE THE ORAL DELIVERY OF HIV-1 PROTEASE INHIBITORS IN DOGS, Pharmaceutical research, 13(3), 1996, pp. 485-487
NOVEL SPIRODIHYDROBENZOFURANLACTAMS AS ANTAGONISTS OF ENDOTHELIN AND AS INHIBITORS OF HIV-1 PROTEASE PRODUCED BY STACHYBOTRYS SP .1. FERMENTATION, ISOLATION AND BIOLOGICAL-ACTIVITY
Authors: ROGGO BE PETERSEN F SILLS M ROESEL JL MOERKER T PETER HH
Citation: Be. Roggo et al., NOVEL SPIRODIHYDROBENZOFURANLACTAMS AS ANTAGONISTS OF ENDOTHELIN AND AS INHIBITORS OF HIV-1 PROTEASE PRODUCED BY STACHYBOTRYS SP .1. FERMENTATION, ISOLATION AND BIOLOGICAL-ACTIVITY, Journal of antibiotics, 49(1), 1996, pp. 13-19
PHARMACOKINETICS OF A NOVEL HIV-1 PROTEASE INHIBITOR INCORPORATED INTO BIODEGRADABLE OR ENTERIC NANOPARTICLES FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION TO MICE
Authors: LEROUX JC COZENS R ROESEL JL GALLI B KUBEL F DOELKER E GURNY R
Citation: Jc. Leroux et al., PHARMACOKINETICS OF A NOVEL HIV-1 PROTEASE INHIBITOR INCORPORATED INTO BIODEGRADABLE OR ENTERIC NANOPARTICLES FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION TO MICE, Journal of pharmaceutical sciences, 84(12), 1995, pp. 1387-1391
BIOSYNTHESIS, PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF A HISTIDINE-LINKED MOMLV PROTEASE
Authors: ROESEL JL LEUTHARDT A
Citation: Jl. Roesel et A. Leuthardt, BIOSYNTHESIS, PURIFICATION AND BIOCHEMICAL-CHARACTERIZATION OF A HISTIDINE-LINKED MOMLV PROTEASE, Journal of cellular biochemistry, 1994, pp. 172-172
CGP-53437, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH POTENT ANTIVIRAL ACTIVITY
Authors: ALTERI E BOLD G COZENS R FAESSLER A KLIMKAIT T LANG M LAZDINS J PONCIONI B ROESEL JL SCHNEIDER P WALKER M WOODSCOOK K
Citation: E. Alteri et al., CGP-53437, AN ORALLY BIOAVAILABLE INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEASE WITH POTENT ANTIVIRAL ACTIVITY, Antimicrobial agents and chemotherapy, 37(10), 1993, pp. 2087-2092
CLONING, EXPRESSION AND PURIFICATION OF A RECOMBINANT POLY-HISTIDINE-LINKED HIV-1 PROTEASE
Authors: LEUTHARDT A ROESEL JL
Citation: A. Leuthardt et Jl. Roesel, CLONING, EXPRESSION AND PURIFICATION OF A RECOMBINANT POLY-HISTIDINE-LINKED HIV-1 PROTEASE, FEBS letters, 326(1-3), 1993, pp. 275-280
Risultati: 1-7 |